Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease

DP Leong, PG Joseph, M McKee, SS Anand… - Circulation …, 2017 - ahajournals.org
In this second part of a 2-part series on the global burden of cardiovascular disease, we
review the proven, effective approaches to the prevention and treatment of cardiovascular …

A review of existing and emerging digital technologies to combat the global trade in fake medicines

TK Mackey, G Nayyar - Expert opinion on drug safety, 2017 - Taylor & Francis
Introduction: The globalization of the pharmaceutical supply chain has introduced new
challenges, chief among them, fighting the international criminal trade in fake medicines. As …

Prevalence and estimated economic burden of substandard and falsified medicines in low-and middle-income countries: a systematic review and meta-analysis

S Ozawa, DR Evans, S Bessias, DG Haynie… - JAMA network …, 2018 - jamanetwork.com
Importance Substandard and falsified medicines burden health systems by diverting
resources to ineffective or harmful therapies, causing medical complications and prolonging …

Global health and the law

LO Gostin, D Sridhar - New England Journal of Medicine, 2014 - Mass Medical Soc
Global Health and the Law | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

[HTML][HTML] Blue crime: Conceptualising transnational organised crime at sea

C Bueger, T Edmunds - Marine Policy, 2020 - Elsevier
Transnational organised crime at sea is a growing international concern. However, and
despite its importance, the concept remains uncertain and contested. This ambiguity has led …

Drivers of antibiotic resistance transmission in low-and middle-income countries from a “one health” perspective—a review

K Iskandar, L Molinier, S Hallit, M Sartelli, F Catena… - Antibiotics, 2020 - mdpi.com
Antibiotic resistance is an ecosystem problem threatening the interrelated human-animal-
environment health under the “One Health” framework. Resistant bacteria arising in one …

Substandard/counterfeit antimicrobial drugs

T Kelesidis, ME Falagas - Clinical microbiology reviews, 2015 - journals.asm.org
Substandard/counterfeit antimicrobial drugs are a growing global problem. The most
common substandard/counterfeit antimicrobials include beta-lactams (among antibiotics) …

Substandard drugs: a potential crisis for public health

A Johnston, DW Holt - British journal of clinical pharmacology, 2014 - Wiley Online Library
Poor‐quality medicines present a serious public health problem, particularly in emerging
economies and develo** countries, and may have a significant impact on the national …

Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment

TK Mackey, BA Liang, R Cuomo, R Hafen… - Clinical microbiology …, 2014 - journals.asm.org
In global health, critical challenges have arisen from infectious diseases, including the
emergence and reemergence of old and new infectious diseases. Emergence and …

Substandard and counterfeit medicines: a systematic review of the literature

T Almuzaini, I Choonara, H Sammons - BMJ open, 2013 - bmjopen.bmj.com
Objective To explore the evidence available of poor-quality (counterfeit and substandard)
medicines in the literature. Design Systematic review. Data sources Databases used were …